Literature DB >> 18649009

Correlates of language impairment in children with galactosaemia.

N L Potter1, J-A C Lazarus, J M Johnson, R D Steiner, L D Shriberg.   

Abstract

PURPOSE: This study describes risk factors associated with language impairment in children with classic galactosaemia.
METHOD: Thirty-three 4-16-year-old participants with classic galactosaemia and a history of speech sound disorders completed a battery of cognitive and language measures and their parents completed a family history questionnaire.
RESULTS: Nine of the sixteen (56%) participants with typical cognitive development and 15 of the 17 (88%) with borderline-low cognitive development had language impairments. Participants with typical cognitive development more often had an expressive language disorder, whereas those with borderline-low cognitive development more often had a mixed receptive-expressive language disorder. Participants with Q188R/Q188R genotypes had increased risk for both cognitive and language impairments. The IQs of younger siblings who did not consume milk postnatally were 10-56 points higher than the IQs of their older siblings with galactosaemia who had consumed milk postnatally. However, 4 of 5 younger siblings who were lactose-restricted from birth had language impairments. Typically-reported risk factors for language disorder, including parental history of speech/learning problems and low parental education level, were not significantly associated with cognitive or language impairments in the present sample of children with galactosaemia.
CONCLUSIONS: Children with galactosaemia and speech disorders have a 4-6 times greater risk for language impairment than children with early speech disorders of unknown origin. Early dietary lactose may increase the risk for cognitive and language impairments; however, the lack of significant associations of language impairment with days of milk consumption, and other familial and educational risk factors, is consistent with prenatal causation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18649009      PMCID: PMC4523884          DOI: 10.1007/s10545-008-0877-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  22 in total

1.  Comparison of the Kaufman Brief Intelligence Test and the Wechsler Intelligence Scale for Children-Third Edition in economically disadvantaged African American youth.

Authors:  J J Grados; K A Russo-Garcia
Journal:  J Clin Psychol       Date:  1999-09

2.  Prevalence of speech delay in 6-year-old children and comorbidity with language impairment.

Authors:  L D Shriberg; J B Tomblin; J L McSweeny
Journal:  J Speech Lang Hear Res       Date:  1999-12       Impact factor: 2.297

3.  Verbal dyspraxia in children with galactosemia.

Authors:  D Nelson
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 4.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

5.  Galactosaemia: relationship of IQ to biochemical control and genotype.

Authors:  M A Cleary; L E Heptinstall; J E Wraith; J H Walter
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Correlations of scores on the Gifted Evaluation Scale with those on WISC-III and Kaufman Brief Intelligence Test for students referred for Gifted Evaluation.

Authors:  E M Levinson; L Folino
Journal:  Psychol Rep       Date:  1994-04

7.  Risk factors for speech delay of unknown origin in 3-year-old children.

Authors:  Thomas F Campbell; Christine A Dollaghan; Howard E Rockette; Jack L Paradise; Heidi M Feldman; Lawrence D Shriberg; Diane L Sabo; Marcia Kurs-Lasky
Journal:  Child Dev       Date:  2003 Mar-Apr

8.  A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine.

Authors:  F R Manis; L B Cohn; C McBride-Chang; J A Wolff; F R Kaufman
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

9.  Developmental aspects of galactosemia from infancy to childhood.

Authors:  K Fishler; R Koch; G N Donnell; E Wenz
Journal:  Clin Pediatr (Phila)       Date:  1980-01       Impact factor: 1.168

Review 10.  Effects of galactosemia in utero.

Authors:  J B Holton
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

View more
  27 in total

1.  The neuropsychological profile of galactosaemia.

Authors:  Claire M Doyle; Shelley Channon; Danuta Orlowska; Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

2.  Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia.

Authors:  Gerard T Berry; Louis J Elsas
Journal:  J Inherit Metab Dis       Date:  2010-11-30       Impact factor: 4.982

3.  Differential phonological awareness skills in children with classic galactosemia: a descriptive study of four cases.

Authors:  Fiona M Lewis; David J Coman; Maryann Syrmis; Sarah Kilcoyne; Bruce E Murdoch
Journal:  JIMD Rep       Date:  2012-12-29

4.  Living situation, occupation and health-related quality of life in adult patients with classic galactosemia.

Authors:  Björn Hoffmann; Nico Dragano; Susanne Schweitzer-Krantz
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

5.  Cross-sectional analysis of speech and cognitive performance in 32 patients with classic galactosemia.

Authors:  Björn Hoffmann; Udo Wendel; Susanne Schweitzer-Krantz
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982

6.  Developmental Outcomes of School-Age Children with Duarte Galactosemia: A Pilot Study.

Authors:  Mary Ellen Lynch; Nancy L Potter; Claire D Coles; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2015-02-15

7.  Motor and speech disorders in classic galactosemia.

Authors:  Nancy L Potter; Yves Nievergelt; Lawrence D Shriberg
Journal:  JIMD Rep       Date:  2013-04-02

8.  Voice disorders in children with classic galactosemia.

Authors:  Nancy L Potter
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

9.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

10.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.